HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution

Lance M. Villeneuve, Phillip R. Purnell, Kelly L. Stauch, Shannon E. Callen, Shilpa J Buch, Howard S Fox

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

With the advent of the combination antiretroviral therapy era (cART), the development of AIDS has been largely limited in the USA. Unfortunately, despite the development of efficacious treatments, HIV-1-associated neurocognitive disorders (HAND) can still develop, and as many HIV-1 positive individuals age, the prevalence of HAND is likely to rise because HAND manifests in the brain with very low levels of virus. However, the mechanism producing this viral disorder is still debated. Interestingly, HIV-1 infection exposes neurons to proteins including Tat, Nef, and Vpr which can drastically alter mitochondrial properties. Mitochondrial dysfunction has been posited to be a cornerstone of the development of numerous neurodegenerative diseases. Therefore, we investigated mitochondria in an animal model of HAND. Using an HIV-1 transgenic rat model expressing seven of the nine HIV-1 viral proteins, mitochondrial functional and proteomic analysis were performed on a subset of mitochondria that are particularly sensitive to cellular changes, the neuronal synaptic mitochondria. Quantitative mass spectroscopic studies followed by statistical analysis revealed extensive proteome alteration in this model paralleling mitochondrial abnormalities identified in HIV-1 animal models and HIV-1-infected humans. Novel mitochondrial protein changes were discovered in the electron transport chain (ETC), the glycolytic pathways, mitochondrial trafficking proteins, and proteins involved in various energy pathways, and these findings correlated well with the function of the mitochondria as assessed by a mitochondrial coupling and flux assay. By targeting these proteins and proteins upstream in the same pathway, we may be able to limit the development of HAND.

Original languageEnglish (US)
Pages (from-to)564-574
Number of pages11
JournalJournal of neurovirology
Volume22
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Transgenic Rats
HIV-1
Mitochondria
Mitochondrial Proteins
Animal Models
tat Gene Products
Viral Proteins
Protein Transport
Proteome
Electron Transport
Neurodegenerative Diseases
Proteomics
HIV Infections
Acquired Immunodeficiency Syndrome
Proteins

Keywords

  • HIV-1-associated neurocognitive disorders
  • Mitochondria
  • Neurodegeneration
  • neuroAIDS

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Virology

Cite this

HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution. / Villeneuve, Lance M.; Purnell, Phillip R.; Stauch, Kelly L.; Callen, Shannon E.; Buch, Shilpa J; Fox, Howard S.

In: Journal of neurovirology, Vol. 22, No. 5, 01.10.2016, p. 564-574.

Research output: Contribution to journalArticle

Villeneuve, Lance M. ; Purnell, Phillip R. ; Stauch, Kelly L. ; Callen, Shannon E. ; Buch, Shilpa J ; Fox, Howard S. / HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution. In: Journal of neurovirology. 2016 ; Vol. 22, No. 5. pp. 564-574.
@article{c711c4f686d2465ea62952a167a014d8,
title = "HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution",
abstract = "With the advent of the combination antiretroviral therapy era (cART), the development of AIDS has been largely limited in the USA. Unfortunately, despite the development of efficacious treatments, HIV-1-associated neurocognitive disorders (HAND) can still develop, and as many HIV-1 positive individuals age, the prevalence of HAND is likely to rise because HAND manifests in the brain with very low levels of virus. However, the mechanism producing this viral disorder is still debated. Interestingly, HIV-1 infection exposes neurons to proteins including Tat, Nef, and Vpr which can drastically alter mitochondrial properties. Mitochondrial dysfunction has been posited to be a cornerstone of the development of numerous neurodegenerative diseases. Therefore, we investigated mitochondria in an animal model of HAND. Using an HIV-1 transgenic rat model expressing seven of the nine HIV-1 viral proteins, mitochondrial functional and proteomic analysis were performed on a subset of mitochondria that are particularly sensitive to cellular changes, the neuronal synaptic mitochondria. Quantitative mass spectroscopic studies followed by statistical analysis revealed extensive proteome alteration in this model paralleling mitochondrial abnormalities identified in HIV-1 animal models and HIV-1-infected humans. Novel mitochondrial protein changes were discovered in the electron transport chain (ETC), the glycolytic pathways, mitochondrial trafficking proteins, and proteins involved in various energy pathways, and these findings correlated well with the function of the mitochondria as assessed by a mitochondrial coupling and flux assay. By targeting these proteins and proteins upstream in the same pathway, we may be able to limit the development of HAND.",
keywords = "HIV-1-associated neurocognitive disorders, Mitochondria, Neurodegeneration, neuroAIDS",
author = "Villeneuve, {Lance M.} and Purnell, {Phillip R.} and Stauch, {Kelly L.} and Callen, {Shannon E.} and Buch, {Shilpa J} and Fox, {Howard S}",
year = "2016",
month = "10",
day = "1",
doi = "10.1007/s13365-016-0424-9",
language = "English (US)",
volume = "22",
pages = "564--574",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution

AU - Villeneuve, Lance M.

AU - Purnell, Phillip R.

AU - Stauch, Kelly L.

AU - Callen, Shannon E.

AU - Buch, Shilpa J

AU - Fox, Howard S

PY - 2016/10/1

Y1 - 2016/10/1

N2 - With the advent of the combination antiretroviral therapy era (cART), the development of AIDS has been largely limited in the USA. Unfortunately, despite the development of efficacious treatments, HIV-1-associated neurocognitive disorders (HAND) can still develop, and as many HIV-1 positive individuals age, the prevalence of HAND is likely to rise because HAND manifests in the brain with very low levels of virus. However, the mechanism producing this viral disorder is still debated. Interestingly, HIV-1 infection exposes neurons to proteins including Tat, Nef, and Vpr which can drastically alter mitochondrial properties. Mitochondrial dysfunction has been posited to be a cornerstone of the development of numerous neurodegenerative diseases. Therefore, we investigated mitochondria in an animal model of HAND. Using an HIV-1 transgenic rat model expressing seven of the nine HIV-1 viral proteins, mitochondrial functional and proteomic analysis were performed on a subset of mitochondria that are particularly sensitive to cellular changes, the neuronal synaptic mitochondria. Quantitative mass spectroscopic studies followed by statistical analysis revealed extensive proteome alteration in this model paralleling mitochondrial abnormalities identified in HIV-1 animal models and HIV-1-infected humans. Novel mitochondrial protein changes were discovered in the electron transport chain (ETC), the glycolytic pathways, mitochondrial trafficking proteins, and proteins involved in various energy pathways, and these findings correlated well with the function of the mitochondria as assessed by a mitochondrial coupling and flux assay. By targeting these proteins and proteins upstream in the same pathway, we may be able to limit the development of HAND.

AB - With the advent of the combination antiretroviral therapy era (cART), the development of AIDS has been largely limited in the USA. Unfortunately, despite the development of efficacious treatments, HIV-1-associated neurocognitive disorders (HAND) can still develop, and as many HIV-1 positive individuals age, the prevalence of HAND is likely to rise because HAND manifests in the brain with very low levels of virus. However, the mechanism producing this viral disorder is still debated. Interestingly, HIV-1 infection exposes neurons to proteins including Tat, Nef, and Vpr which can drastically alter mitochondrial properties. Mitochondrial dysfunction has been posited to be a cornerstone of the development of numerous neurodegenerative diseases. Therefore, we investigated mitochondria in an animal model of HAND. Using an HIV-1 transgenic rat model expressing seven of the nine HIV-1 viral proteins, mitochondrial functional and proteomic analysis were performed on a subset of mitochondria that are particularly sensitive to cellular changes, the neuronal synaptic mitochondria. Quantitative mass spectroscopic studies followed by statistical analysis revealed extensive proteome alteration in this model paralleling mitochondrial abnormalities identified in HIV-1 animal models and HIV-1-infected humans. Novel mitochondrial protein changes were discovered in the electron transport chain (ETC), the glycolytic pathways, mitochondrial trafficking proteins, and proteins involved in various energy pathways, and these findings correlated well with the function of the mitochondria as assessed by a mitochondrial coupling and flux assay. By targeting these proteins and proteins upstream in the same pathway, we may be able to limit the development of HAND.

KW - HIV-1-associated neurocognitive disorders

KW - Mitochondria

KW - Neurodegeneration

KW - neuroAIDS

UR - http://www.scopus.com/inward/record.url?scp=84957542019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957542019&partnerID=8YFLogxK

U2 - 10.1007/s13365-016-0424-9

DO - 10.1007/s13365-016-0424-9

M3 - Article

VL - 22

SP - 564

EP - 574

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 5

ER -